Live News EQUITY FLASH L impact Oct 30, 2026, 12:40 PM UTC Moleculin Completes Patient Dosing in MIRACLE Trial Part A Moleculin says a comprehensive data readout remains on track for Q1 2027. MBRX SquawkNews Desk